Clinical Trial Update: CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CLAGE sequential conditioning with Flu-Bu in refractory acute leukemia undergoing allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Stem Cell Transplantation
• Hematologic Cancer
• Leukemia

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Refractory Hematologic Cancer, Allogeneic Stem Cell Transplantation | Phase 2 | Status: COMPLETED